The European Commission will unveil its long-awaited EU pharmaceutical strategy on 24 November in an effort to improve access to affordable medicines and “harness the benefits of digital and emerging science and technology.”
The strategy will address both short-term challenges related to COVID-19 “and of course longer-term challenges linked to unmet medical needs, strategic autonomy and sustainable health care systems,” EU health
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?